- In March 2026, Cadre Holdings, Inc. reported fourth-quarter 2025 sales of US$167.22 million, down from US$175.98 million a year earlier, alongside lower quarterly earnings per share, even as full-year 2025 revenue and net income rose versus 2024 and the company issued 2026 net sales guidance of US$736 million to US$758 million.
- Management highlighted a growing backlog and strong balance sheet while signaling an active M&A pipeline in public safety and nuclear markets, indicating a push to use acquisitions to broaden capabilities and offset recent contract timing and margin pressures.
- We’ll now explore how Cadre’s weaker quarter, alongside its ambitious M&A plans, may reshape the company’s existing investment narrative.
Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
Cadre Holdings Investment Narrative Recap
To own Cadre Holdings, you have to believe in steady, mission critical demand for safety and protective gear, plus disciplined use of acquisitions to deepen that niche. The weak fourth quarter and sharp share price reaction primarily highlight how sensitive near term sentiment is to contract timing and margins, but they do not yet appear to overturn the core thesis. The biggest near term catalyst remains execution on the 2026 sales outlook, while integration and contract delays stay the key risks.
The most relevant update here is Cadre’s 2026 net sales guidance of US$736 million to US$758 million, set just as it reported a softer fourth quarter. That target now sits alongside management’s emphasis on an “active” M&A pipeline in public safety and nuclear markets, making future deal quality and integration a meaningful swing factor for whether guidance proves realistic and whether Cadre can smooth out the lumpiness from large contracts and regulatory driven project pauses.
Yet behind Cadre’s growing backlog and confident guidance, investors should also be aware of the risk that ongoing contract pushouts and integration challenges could...
Read the full narrative on Cadre Holdings (it's free!)
Cadre Holdings’ narrative projects $787.2 million revenue and $74.8 million earnings by 2028. This requires 11.2% yearly revenue growth and about a $36.7 million earnings increase from $38.1 million today.
Uncover how Cadre Holdings' forecasts yield a $48.80 fair value, a 51% upside to its current price.
Exploring Other Perspectives
Some of the lowest ranked analysts were already cautious, assuming revenue of about US$782 million and earnings of roughly US$72 million by 2028, and this softer quarter could either reinforce their concerns about contract dependency or prompt them to reassess if Cadre’s acquisition pipeline and guidance justify a less pessimistic view.
Explore 2 other fair value estimates on Cadre Holdings - why the stock might be worth as much as 78% more than the current price!
Decide For Yourself
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Cadre Holdings research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Cadre Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Cadre Holdings' overall financial health at a glance.
Searching For A Fresh Perspective?
The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:
- Find 49 companies with promising cash flow potential yet trading below their fair value.
- AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com